Esperion Therapeutics reported $18.84M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 13538M 1348M
Alnylam Pharmaceuticals ALNY:US $ 213.26M 45.28M
Amarin AMRN:US $ 94.63M 49.86M
Amgen AMGN:US $ 6238M 608M
Biogen BIIB:US $ 2531.8M 202M
Biomarin Pharmaceutical BMRN:US $ 519.36M 69.55M
Cytokinetics CYTK:US $ 1.15M 54.45M
Daiichi Sankyo 4568:JP Y 233925M 47076M
Eli Lilly And LLY:US $ 7810M 189.9M
Esperion Therapeutics ESPR:US $ 18.84M 3.44M
Geron GERN:US $ 0.12M 0.92M
Halozyme Therapeutics HALO:US $ 117.28M 15.28M
Heron Therapeutics HRTX:US $ 23.46M 2.8M
Intercept Pharmaceuticals ICPT:US $ 88.58M 3.82M
Intra Cellular Therapies ITCI:US $ 35M 9.32M
Merk MRK:US $ 15901M 2380M
Moderna Inc MRNA:US 6.07B 1.14B
Nektar Therapeutics NKTR:US $ 24.82M 0.19M
Pfizer PFE:US $ 25661M 2026M
Ptc Therapeutics PTCT:US $ 148.74M 16.49M
Puma Biotechnology PBYI:US $ 45.74M 9.62M
Regeneron Pharmaceuticals REGN:US $ 2965.1M 1986.6M
Sarepta Therapeutics SRPT:US $ 210.83M 9.37M
Seattle Genetics SGEN:US $ 426.46M 3.39M
United Therapeutics UTHR:US $ 461.9M 46.7M
Vanda Pharmaceuticals VNDA:US $ 60.19M 7.83M